Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ehninger

Showing results (281-290 of 403) with videos related to

Pageof 41
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2011
Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting systemChristoph Röllig, Martin Bornhäuser, Christian Thiede, et al.
Hepatology (Baltimore, Md.)|May 31, 2016
Detection of hepatitis b virus DNA in the blood of a stem cell donor after granulocyte colony-stimulating factor treatmentMichael Punzel, Patrick Medd, Hannah Hunter, et al.
Oncoimmunology|May 17, 2017
A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platformSusann Albert, Claudia Arndt, Anja Feldmann, et al.
JAMA Oncology|July 14, 2018
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia RelapseMohamed A Kharfan-Dabaja, Myriam Labopin, Emmanuelle Polge, et al.
Haematologica|August 31, 2019
The prevalence of extramedullary acute myeloid leukemia detected by <sup>18</sup>FDG-PET/CT: final results from the prospective PETAML trialFriedrich Stölzel, Tors Lüer, Steffen Löck, et al.
Blood|May 5, 2011
Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemiaMartin Bornhäuser, Christian Thiede, Uwe Platzbecker, et al.
Transplantation|February 9, 2012
Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantationFriedrich Stölzel, Karl Hackmann, Friederike Kuithan, et al.
Haematologica|November 3, 2009
Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantationMartin Bornhäuser, Uta Oelschlaegel, Uwe Platzbecker, et al.
Blood|October 25, 2003
Early prediction of response in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinibBarbara Wassmann, Heike Pfeifer, Urban J Scheuring, et al.
Cancer|January 9, 2019
Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and overNicole Santoro, Myriam Labopin, Fabio Ciceri, et al.
Pageof 41

Showing results (281-290 of 403) with videos related to

Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2011
Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting systemChristoph Röllig, Martin Bornhäuser, Christian Thiede, et al.
Hepatology (Baltimore, Md.)|May 31, 2016
Detection of hepatitis b virus DNA in the blood of a stem cell donor after granulocyte colony-stimulating factor treatmentMichael Punzel, Patrick Medd, Hannah Hunter, et al.
Oncoimmunology|May 17, 2017
A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platformSusann Albert, Claudia Arndt, Anja Feldmann, et al.
JAMA Oncology|July 14, 2018
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia RelapseMohamed A Kharfan-Dabaja, Myriam Labopin, Emmanuelle Polge, et al.
Haematologica|August 31, 2019
The prevalence of extramedullary acute myeloid leukemia detected by <sup>18</sup>FDG-PET/CT: final results from the prospective PETAML trialFriedrich Stölzel, Tors Lüer, Steffen Löck, et al.
Blood|May 5, 2011
Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemiaMartin Bornhäuser, Christian Thiede, Uwe Platzbecker, et al.
Transplantation|February 9, 2012
Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantationFriedrich Stölzel, Karl Hackmann, Friederike Kuithan, et al.
Haematologica|November 3, 2009
Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantationMartin Bornhäuser, Uta Oelschlaegel, Uwe Platzbecker, et al.
Blood|October 25, 2003
Early prediction of response in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinibBarbara Wassmann, Heike Pfeifer, Urban J Scheuring, et al.
Cancer|January 9, 2019
Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and overNicole Santoro, Myriam Labopin, Fabio Ciceri, et al.
Pageof 41